Corrigendum to “ Utilisation trend of long-acting insulin analogues including biosimilars across Europe: findings and implications” (BioMed Research International (2021) 2021 (9996193) DOI: 10.1155/2021/9996193) /

Brian Godman; Magdalene Wladysiuk; Stuart McTaggart; Amanj Kurdi; Eleonora Allocati; Mihajlo Jakovljevic; Francis Kalemeera; Iris Hoxha; Anna Nachtnebel; Robert Sauermann; Manfred Hinteregger; Vanda Marković-Peković; Biljana Tubic; Guenka Petrova; Konstantin Tachkov; Juraj Slabý; Radka Nejezchlebova; Iva Selke Krulichová; Ott Laius; Gisbert Selke; Irene Langner; András Harsanyi; András Inotai; Arianit Jakupi; Svens Henkuzens; Kristina Garuolienė; Jolanta Gulbinovič; Patricia Vella Bonanno; Jakub Rutkowski; Skule Ingeberg; Øyvind Melien; Ileana Mardare; Jurij Fürst; Sean Macbride-Stewart; Carol Holmes; Caridad Pontes; Corinne Zara; Marta Turu Pedrola; Mikael Hoffmann; Vasileios Kourafalos; Alice Pisana; Rita Banzi; Stephen Campbell; Bjorn Wettermark; Sean MacBride-Stewart

doi:10.1155/2023/9757348

Title	Corrigendum to “ Utilisation trend of long-acting insulin analogues including biosimilars across Europe: findings and implications” (BioMed Research International (2021) 2021 (9996193) DOI: 10.1155/2021/9996193) /
Authors	Godman, Brian ; Wladysiuk, Magdalene ; McTaggart, Stuart ; Kurdi, Amanj ; Allocati, Eleonora ; Jakovljevic, Mihajlo ; Kalemeera, Francis ; Hoxha, Iris ; Nachtnebel, Anna ; Sauermann, Robert ; Hinteregger, Manfred ; Marković-Peković, Vanda ; Tubic, Biljana ; Petrova, Guenka ; Tachkov, Konstantin ; Slabý, Juraj ; Nejezchlebova, Radka ; Krulichová, Iva Selke ; Laius, Ott ; Selke, Gisbert ; Langner, Irene ; Harsanyi, András ; Inotai, András ; Jakupi, Arianit ; Henkuzens, Svens ; Garuolienė, Kristina ; Gulbinovič, Jolanta ; Bonanno, Patricia Vella ; Rutkowski, Jakub ; Ingeberg, Skule ; Melien, Øyvind ; Mardare, Ileana ; Fürst, Jurij ; Macbride-Stewart, Sean ; Holmes, Carol ; Pontes, Caridad ; Zara, Corinne ; Pedrola, Marta Turu ; Hoffmann, Mikael ; Kourafalos, Vasileios ; Pisana, Alice ; Banzi, Rita ; Campbell, Stephen ; Wettermark, Bjorn ; MacBride-Stewart, Sean
DOI	10.1155/2023/9757348
Full Text
Is Part of	BioMed research international.. Hindawi Limited. 2023, vol. 2023, art. no. 9757348, p. [1-3].. ISSN 2314-6133. eISSN 2314-6141
Abstract [eng]	In the article titled “Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications” [1], the captions of Figures 3 and 4 were incorrect. The corrected captions for Figures 3 and 4 appear below. (Figure Presented). Figure 4: Utilisation of insulin glargine biosimilar (100 IU/ml) as a % of total insulin glargine 100 IU/ml (DDD based) over time across Europe.
Published	Hindawi Limited
Type	Journal article
Language	English
Publication date	2023
CC license

„Corrigendum to “ Utilisation trend of long-acting insulin analogues including biosimilars across Europe: findings and implications” (BioMed Research International (2021) 2021 (9996193) DOI: 10.1155/2021/9996193) /“